CANC

Tema Oncology ETF

41.57

Sep 15 • 3:59 PM ET 0.00 (0.00%)

Financial Exchange Traded Fund USA NASD

Category	Global or ExUS Equities - Industry Sector
Sponsor	Tema
Fund Family
Index	-
Index Weighting
Active/Passive
Dividend TTM	0.02 (0.05%)
Dividend Ex-Date	Dec 10, 2025
Dividend Gr. 3/5Y	- -
Expense	0.75%
Inverse/Leveraged
IPO	Aug 16, 2023

Asset Type	Equities (Stocks)
ETF Type
Bond Type
Average Maturity
Commodity Type
Quant Type
ESG Type
Dividend Type
Structure Type
Growth/Value
Market Cap
Option/Short	No / Yes

Tags	Global
Tags	equity
Tags	healthcare
Tags	-
Tags	-
Tags	-
Tags	-
Sector/Theme
Region
SMA20	-4.71%
SMA50	-1.99%
SMA200	8.63%

Return% 1Y	51.56%
Return% 3Y	21.04%
Return% 5Y	-
Return% 10Y
Return% SI
Flows% 1M	3.87%
Flows% 3M	4.56%
Flows% YTD	41.56%
Flows% 1Y
Flows% 3Y
Flows% 5Y
Trades

Total Holdings	59
AUM	208.70M
NAV/sh
52W High	45.41 -8.46%
52W Low	26.62 56.16%
Volatility	1.77% 1.84%
ATR (14)	0.88
RSI (14)	40.35
Beta	0.73
Rel Volume	0.00
Avg Volume	33.80K
Volume	0

Perf Week	-3.53%
Perf Month	-2.56%
Perf Quarter	10.94%
Perf Half Y	13.38%
Perf YTD	19.73%
Perf Year	52.86%
Perf 3Y	73.55%
Perf 5Y	-
Perf 10Y	-
Prev Close	41.57
Price	41.57
Change %	0.00%

Sep-08-26 04:50PM	AI, Cancer Vaccines, and Next-Gen Medicine (Zacks)
Jan-09-26 10:00AM	Here's Why Biotech ETFs Are Rallying Hard (Zacks)
Dec-02-25 06:00AM	Temas Oncology ETF (CANC) Surpasses $100m in Assets Amidst Strong 2025 Performance (Business Wire)
Nov-26-25 10:00AM	Be Thankful to These ETFs This Year (Zacks)
Nov-21-25 08:00AM	Inside the Recent Strength in Biotech ETFs (Zacks)
06:00AM	Loading…
Oct-20-25 06:00AM	Biotech ETFs Bounce Back in 2025: Here's Why (Zacks)

Tema Oncology ETF seeks to provide long-term growth. Under normal circumstances, the fund seeks to achieve its investment objective by investing at least 80% of its net assets, which include borrowings for investment purposes, in publicly listed companies that derive at least 50% of revenues from oncology. The fund is non-diversified.

open in yahoo | open in marketwatch | open in google

CANC

Tema Oncology ETF

Upgrade your Finviz experience